Erratum for Hong et al. "Outcome of Undersized Drug-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Graft Lesions" Am J Cardiol 2010;105:179-185 (DOI:10.1016/j.amjcard.2009.09.006);Outcome of Undersized Drug-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Graft Lesions

American Journal of Cardiology

Volumn 105, Issue 2, 2010, Pages 179-185

  Hong, Young Joon ^a   Pichard, Augusto D ^b   Mintz, Gary S ^c   Kim, Sang Wook ^d   Lee, Sung Yun ^e   Kim, Seok Yeon ^f   Ahn, Youngkeun ^a   Jeong, Myung Ho ^a   Satler, Lowell F ^b   Kent, Kenneth M ^b   Suddath, William O ^b   Weissman, Neil J ^b   Kang, Jung Chaee ^a   Waksman, Ron ^f  

^a Chonnam National University Medical School   (South Korea)

^b Washington Hospital Center   (Colombia)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d Chung Ang University College of Medicine   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Seoul Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CREATINE KINASE BLOOD LEVEL; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PHLEBOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME; VEIN BLOOD FLOW; VEIN DIAMETER; VEIN GRAFT DISEASE;

EID: 73149088212     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.03.049     Document Type: Erratum

References (28)

1. de Feyter P.J., van Suylen R.J., de Jaegere P.P., Topol E.J., and Serruys P.W. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 89 (1993) 1539-1549
2. Trono R., Sutton C., Hollman J., Suit P., and Ratliff N.B. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts. Cleve Clin J Med 56 (1989) 581-584
3. Waller B.F., Rothbaum D.A., Gorfinkel H.J., Ulbright T.M., Linnemeier T.J., and Berger S.M. Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein grafts. J Am Coll Cardiol 4 (1984) 784-792
4. Kaplan B.M., Benzuly K.H., Kinn J.W., Bowers T.R., Tilli F.V., Grines C.L., O'Neill W.W., and Safian R.D. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Catheter Cardiovasc Diagn 39 (1996) 113-118
5. Baim D.S., and Carrozza Jr. J.J. Understanding the "no-reflow" problem. Catheter Cardiovasc Diagn 1 (1996) 7-8
6. Piana R.N., Paik G.Y., Moscucci M., Cohen D.J., Gibson C.M., Kugelmass A.D., Carrozza Jr. J.P., Kuntz R.E., and Baim D.S. Incidence and treatment of "no-reflow" after percutaneous coronary interventions. Circulation 89 (1994) 2514-2518
7. Abbo K.M., Dooris M., Glazier S., O'Neill W.W., Byrd D., Grines C.L., and Safian R.D. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 75 (1995) 778-782
8. Morishima I., Sone T., Mokuno S., Taga S., Shimauchi A., Oki Y., Kondo J., Tsuboi H., and Sassa H. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 130 (1995) 239-243
9. Lefkovits J., Holmes D.R., Califf R.M., Safian R.D., Pieper K., Keeler G., and Topol E.J. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II Trial. Circulation 92 (1995) 734-740
10. Hong M.K., Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Kent K.M., Satler L.F., Stone G.W., and Leon M.B. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100 (1999) 2400-2405
11. de Feyter P., van Suylen R.J., de Jaegere P.P., Topol E.J., and Serruys P.W. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 21 (1993) 1539-1549
12. Hong M.K., Mehran R., Dangas G., Mintz G.S., Lansky A., Kent K.M., Pichard A.D., Satler L.F., Stone G.W., and Leon M.B. Are we making progress with percutaneous saphenous vein graft treatment?. A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 38 (2001) 150-154
13. Dooris M., Hoffmann M., Glazier S., Juran N., Reddy V., Grines C.L., Pavlides G.S., Schreiber T., O'Neil W.W., and Safian R.D. Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. J Am Coll Cardiol 25 (1995) 1700-1705
14. Verbin C.S., White R.A., Donayre C.E., and Kopchok G.E. The ideal guidance imaging system for endovascular interventions. J Cardiovasc Surg 37 (1996) 5-9
15. Elezi S., Kastrati A., Neumann F.J., Hadamitzky M., Dirschinger J., and Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation 98 (1998) 1875-1880
16. Iakovou I., Dangas G., Mintz G.S., Mehran R., Kobayashi Y., Aymong E.D., Hirose M., Ashby D.T., Lansky A.J., Stone G.W., Leon M.B., and Moses J.W. Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol 93 (2004) 963-968
17. Gronenschild E., Janssen J., and Tijdens F. CAAS II: a second generation system for off-line and on-line quantitative coronary angiography. Catheter Cardiovasc Diagn 33 (1994) 61-75
18. Thrombolysis in Myocardial ischemia (TIMI) IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation 89 (1994) 1545-1556
19. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
20. Hong M.K., Mintz G.S., Hong M.K., Abizaid A.S., Pichard A.D., Satler L.F., Kent K.M., and Leon M.B. Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts. Am J Cardiol 84 (1999) 992-998
21. Walts A.E., Fishbein M.C., Sustaita H., and Matloff J.M. Ruptured atheromatous plaques in saphenous vein coronary bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation 65 (1982) 197-201
22. Mautner S.L., Mautner G.C., Hunsberger S.A., and Roberts W.C. Comparison of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary artery in the same men. Am J Cardiol 70 (1992) 1380-1387
23. Coolong A., Baim D.S., Kuntz R.E., O'Malley A.J., Marulkar S., Cutlip D.E., Popma J.J., and Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3,958 patients. Circulation 117 (2008) 790-797
24. Ellis S.G., Lincoff A.M., Miller D., Tcheng J.E., Kleiman N.S., Kereiakes D., Califf R., Topol E.J., and EPIC and EPILOG Investigators. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology: evaluation of 7E3 for the prevention of ischemic complications. Evaluation of PTCA to improve long-term outcome with abciximab GPIIb/IIIa receptor blockade. J Am Coll Cardiol 32 (1998) 1619-1623
25. Baim D.S., Wahr D., George B., Leon M.B., Greenberg J., Cutlip D.E., Kaya U., Popma J.J., Ho K.K., Kuntz R.E., and Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 105 (2002) 1285-1290
26. Stone G.W., Rogers C., Hermiller J., Feldman R., Hall P., Haber R., Masud A., Cambier P., Caputo R.P., Turco M., Kovach R., Brodie B., Herrmann H.C., Kuntz R.E., Popma J.J., Ramee S., Cox D.A., and FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 108 (2003) 548-553
27. Mauri L., Cox D., Hermiller J., Massaro J., Wahr J., Tay S.W., Jonas M., Popma J.J., Pavliska J., Wahr D., and Rogers C. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 50 (2007) 1442-1449
28. Kim S.W., Mintz G.S., Ohlmann P., Hassani S.E., Fernandez S., Lu L., Chu W.W., Escolar E., Kuchulakanti P.K., Weigold G., Pichard A.D., Satler L.F., Kent K.M., Suddath W.O., Waksman R., and Weissman N.J. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol 98 (2006) 1206-1211